"Doping" in the Sunscreen Industry and the Problem With Broad-Spectrum Testing in the U.S. with Sophie Bai - podcast episode cover

"Doping" in the Sunscreen Industry and the Problem With Broad-Spectrum Testing in the U.S. with Sophie Bai

Mar 15, 20241 hr 5 minSeason 1Ep. 387
--:--
--:--
Download Metacast podcast app
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episode description

Heard of "doping" when it comes to SPF? Today you'll learn all about it. Sunscreen is the most important step in your morning skincare routine, but there's still so much confusion around it, as well as challenges brands have to overcome in the US that prohibits us from having more sophisticated UV filters. Sophie Bai, biomedical engineer, cancer drug developer and the founder/CEO of Pavise is our guest today, discussing those challenges in sunscreen development and regulation, the classification of sunscreen as a drug, mislabeling of sunscreens, inaccurate SPF claims, flaws in broad spectrum testing, and what separates Pavise Dynamic Age Defense SPF 30 from other sunscreens.


Shop this episode


GlossAngelesPod.com

https://glossangeles.komi.io

CALL US: 424-341-0426

Shop products from our episodes

Join our FB Group: https://www.facebook.com/groups/glossangelespodcast

Instagram: @glossangelspod, @kirbiejohnson, @saratan

Twitter: @glossangelespod, @kirbiejohnson, @saratan

Email: glossangelespodcast@gmail.com



Watch our episodes!

CALL or TEXT US: 424-341-0426

Instagram: @glossangelspod, @kirbiejohnson, @saratan

Twitter: @glossangelespod, @kirbiejohnson, @saratan

Email: glossangelespodcast@gmail.com

Hosted on Acast. See acast.com/privacy for more information.

For the best experience, listen in Metacast app for iOS or Android